Filter
443
Filtered Results: 443
Text search:
genome
Featured
Recommendations
57
New Publications
83
Language
Document type
No document type
177
Studies & Reports
100
Guidelines
85
Manuals
26
Strategic & Response Plan
20
Fact sheets
15
Training Material
10
Situation Updates
5
Resource Platforms
2
Infographics
2
Online Courses
1
Countries / Regions
India
22
Global
18
Western and Central Europe
11
Germany
10
Russia
10
Latin America and the Carribbean
9
Africa
9
South Africa
7
Nigeria
6
Tanzania
6
Brazil
6
Ukraine
6
Uganda
5
Eastern Europe
5
Ethiopia
4
West and Central Africa
4
Middle East and North Africa
4
Liberia
3
Senegal
3
Chad
3
East and Southern Africa
3
South–East Asia Region
3
Sierra Leone
2
Congo, Democratic Republic of
2
Mali
2
Côte d’Ivoire / Ivory Coast
2
Cameroon
2
Niger
2
Haiti
2
South Sudan
2
Kenya
2
Bangladesh
2
Peru
2
Colombia
2
Bolivia
2
Angola
2
Western Pacific Region
2
Asia
2
Venezuela
2
France
2
Spain
2
Guinea
1
Burkina Faso
1
Morocco
1
USA
1
Saudi Arabia
1
Ghana
1
Philippines
1
Somalia
1
Nepal
1
Pakistan
1
Iraq
1
Jordan
1
Lebanon
1
Turkey
1
Egypt
1
Syria
1
Cambodia
1
China
1
Rwanda
1
Indonesia
1
Mauritania
1
Malawi
1
Mozambique
1
Sudan
1
Benin
1
Argentina
1
Dominican Republic
1
North Macedonia
1
Cuba
1
Honduras
1
Ecuador
1
El Salvador
1
Libya
1
Guatemala
1
Madagascar
1
Mexico
1
Nicaragua
1
Chile
1
Yemen
1
Eastern Europe and Central Asia
1
Southern Africa
1
Congo-Brazzaville
1
Qatar
1
Kazakhstan
1
Vietnam
1
Denmark
1
Tunisia
1
United Kingdom
1
Portugal
1
Belarus
1
Israel
1
Authors & Publishers
Publication Years
Category
Countries
92
Clinical Guidelines
73
Public Health
23
Pharmacy & Technologies
18
Key Resources
14
Women & Child Health
4
Capacity Building
2
Toolboxes
COVID-19
79
TB
48
Rapid Response
45
NTDs
42
AMR
37
Mental Health
26
Zika
15
HIV
15
Planetary Health
15
Ebola
12
NCDs
10
Refugee
9
Polio
7
Conflict
4
Global Health Education
4
Caregiver
4
Disability
3
Specific Hazards
3
Pharmacy
3
Cholera
2
Health Financing Toolbox
2
South Sudan
1
Natural Hazards
1
WHO published the first COVID-19 Strategic Response and Preparedness Plan (SPRP) on 3 February, 2020. This report highlights the main points of progress that were made up to 30 June 2020 under the three objectives outlined in the SPRP: scaling up international coordination and support; scaling up co...
22 July 2022. This document summarizes current WHO guidance for public health surveillance of coronavirus disease 2019 (COVID-19) in humans caused by infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
The two-year impact report for the Access to COVID-19 Tools (ACT) Accelerator details impact, case studies and timelines of key milestones for the Diagnostics, Therapeutics and Vaccines pillars, as well as the Health Systems and Response Connector.
Zoonotic tuberculosis (TB) is a form of TB in people predominantly caused by the bacterial species, Mycobacterium bovis, which belongs to the M. tuberculosis complex. The implications of zoonotic TB go beyond human health. The organism is host-adapted to cattle, where it is refer...
Interim guidance, 6 October 2021
Direct detection of SARS-CoV-2 viral proteins (antigens) in nasal swabs and other respiratory secretions using lateral flow immunoassays (also known as rapid diagnostic tests, RDTs) offers a faster and less expensive method to test for SARS-CoV-2 than the reference ...
This third edition of the landscape analysis provides regional and country-specific data. This report illustrates the complexities in surveillance of influenza and other respiratory viruses and highlights differences in the countries’ preparedness capacities through charts, infographics, tables, a...
There is no secret to our procedure: the daily scanning of the literature helps us to stay afloat in the never-ending waves of new publications about SARS-CoV-2 and COVID-19. Many papers discussed in the Top 10 will eventually make it into subsequent editions of COVID Reference.
The Global Strategy for Tuberculosis Research and Innovation will support the efforts of governments and other stakeholders to accelerate TB research and innovation, and improve equitable access to the benefits of research.
Availabl in Arabic, Chinese, English, French, Spanish and Russian
Available in Arabic, Chinese, English, French, Portuguese, Russian and Spanish
https://apps.who.int/iris/handle/10665/334254
Available in Arabic, Chinese, English, French, Portuguese, Russian and Spanish
https://apps.who.int/iris/handle/10665/334254
This twelfth version of the WHO living guideline now contains 19 recommendations. This latest update provides updated recommendations for remdesivir, addresses the use of combination therapy with corticosteroids, interleukin-6 (IL-6) receptor blockers and Janus kinase (JAK) inhibitors in patients wi...
Vatican lays out 20 points for a universal and fair destination of vaccines, for a fairer and healthier world
22 December 2020
The COVID-19 vaccine safety guidance manual has been developed upon recommendation and guidance of GACVS members, as well as by experts incorporating current and available information critical to all stakeholders when COVID-19 vaccines will be introduced.
For ease of use, the man...
In line with its decentralization principle, the Ethiopian Health Policy has achieved great progress in improving access to comprehensive HIV/AIDS services to the majority of the population. Both quality and coverage of services have improved significantlysince the initiation...
Meeting Report 27-29 October 2020
The overall goal of the meeting was to discuss recent changes in treatment regimens and diagnostics for drug-resistant TB and to determine how these impact on the definition of XDR-TB, with a view to revising this definition. The pre-existing definition of XDR-TB w...
An Action Framework and annexe to Immunization Agenda 2030 (Draft version)
27 January 2021
